Molecular Docking Service - Neorabio
Neorabio provides molecular docking services that help researchers examine ligand–protein recognition at atomic detail, enabling confident assessment of how candidate molecules interact with biological targets. Docking has long been a central component of structure-based drug design, with early systematic discussions—such as those presented by Meng et al. (2011)—demonstrating its value in identifying plausible binding modes before experimental testing. Neorabio's workflows build on these principles while emphasizing reproducibility, physically consistent poses, and clear interpretation to support downstream decision-making.
